RGNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.13%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,486,734.00

REGENXBIO Insider Trading History Chart

REGENXBIO Share Price & Price History

^$7.83

▼ -0.08 (-1.01%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

REGENXBIO Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/1/2024	Argeris N Karabelas	Director	Sell	10,000	$10.11	$101,100.00	11,286
9/3/2024	Argeris N Karabelas	Director	Sell	10,000	$11.56	$115,600.00	11,286
8/1/2024	Argeris N Karabelas	Director	Sell	10,100	$13.51	$136,451.00	11,286
8/1/2024	Curran Simpson	CEO	Sell	100	$15.00	$1,500.00	170,037
7/29/2024	Argeris N Karabelas	Director	Sell	11,000	$15.04	$165,440.00	11,286
7/29/2024	Curran Simpson	CEO	Sell	9,648	$15.04	$145,105.92	170,137
7/24/2024	Kenneth T Mills	Director	Sell	12,221	$13.78	$168,405.38	408,035
7/17/2024	Kenneth T Mills	Director	Sell	2,210	$13.77	$30,431.70	408,035
7/1/2024	Argeris N Karabelas	Director	Sell	10,000	$11.27	$112,700.00	11,286
5/14/2024	Kenneth T Mills	CEO	Sell	15,000	$15.81	$237,150.00	408,035
4/15/2024	Kenneth T Mills	CEO	Sell	15,000	$18.19	$272,850.00	408,035
3/14/2024	Kenneth T Mills	CEO	Sell	15,000	$21.86	$327,900.00	408,035
3/5/2024	Steve Pakola	Insider	Sell	12,878	$28.36	$365,220.08	107,192
2/14/2024	Kenneth T Mills	CEO	Sell	15,000	$16.76	$251,400.00	408,035
1/16/2024	Kenneth T Mills	CEO	Sell	45,000	$15.18	$683,100.00	408,035
1/3/2024	Steve Pakola	Insider	Sell	17,237	$17.39	$299,751.43	107,192
12/19/2023	Kenneth T Mills	CEO	Sell	45,000	$19.68	$885,600.00	355,289
8/30/2022	Vittal Vasista	CFO	Sell	2,400	$30.24	$72,576.00	135,160
8/1/2022	Vittal Vasista	CFO	Sell	2,400	$31.25	$75,000.00	155,240
7/13/2022	Vittal Vasista	CFO	Sell	4,332	$30.01	$130,003.32	158,108

See Full Table

SEC Filings (Institutional Ownership Changes) for REGENXBIO (NASDAQ:RGNX)

88.08% of REGENXBIO stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

REGENXBIO Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/18/2025	Alpine Global Management LLC	22,687	$0.18M	0.0%	N/A	0.046%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	72,183	$0.56M	0.0%	+9.2%	0.146%
2/17/2025	Squarepoint Ops LLC	37,230	$0.29M	0.0%	-6.2%	0.075%
2/17/2025	Two Sigma Advisers LP	180,000	$1.39M	0.0%	+164.7%	0.363%
2/17/2025	Two Sigma Investments LP	389,428	$3.01M	0.0%	+209.2%	0.786%
2/17/2025	Sherbrooke Park Advisers LLC	24,330	$0.19M	0.1%	-18.1%	0.049%
2/17/2025	Rafferty Asset Management LLC	93,821	$0.73M	0.0%	+22.4%	0.189%
2/17/2025	Redmile Group LLC	4,794,780	$37.06M	2.6%	-2.0%	9.679%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	57,841	$0.45M	0.1%	N/A	0.117%
2/17/2025	ProShare Advisors LLC	15,314	$0.12M	0.0%	+22.4%	0.031%
2/17/2025	Millennium Management LLC	1,322,344	$10.22M	0.0%	+406.3%	2.669%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	100,452	$0.78M	0.0%	+2.9%	0.203%
2/17/2025	Laurion Capital Management LP	10,188	$79K	0.0%	N/A	0.021%
2/17/2025	Integral Health Asset Management LLC	900,000	$6.96M	0.6%	-29.4%	1.817%
2/17/2025	Hudson Bay Capital Management LP	308,100	$2.38M	0.0%	+43.3%	0.622%
2/17/2025	Graham Capital Management L.P.	28,542	$0.22M	0.0%	+59.8%	0.058%
2/17/2025	D. E. Shaw & Co. Inc.	63,377	$0.49M	0.0%	+15.0%	0.128%
2/17/2025	Deutsche Bank AG	200,375	$1.55M	0.0%	+8.5%	0.404%
2/17/2025	Corton Capital Inc.	13,276	$0.10M	0.1%	N/A	0.027%
2/17/2025	Cubist Systematic Strategies LLC	361,313	$2.79M	0.0%	N/A	0.729%
2/17/2025	Brevan Howard Capital Management LP	41,160	$0.32M	0.0%	N/A	0.083%
2/17/2025	Balyasny Asset Management L.P.	1,187,102	$9.18M	0.0%	+6.0%	2.396%
2/17/2025	Bank of America Corp DE	281,204	$2.17M	0.0%	-37.0%	0.568%
2/17/2025	BNP Paribas Financial Markets	96,093	$0.74M	0.0%	+370.1%	0.194%
2/17/2025	Ameriprise Financial Inc.	284,521	$2.20M	0.0%	+4.7%	0.574%
2/14/2025	Jane Street Group LLC	164,911	$1.28M	0.0%	+325.3%	0.333%
2/14/2025	PDT Partners LLC	63,015	$0.49M	0.0%	N/A	0.127%
2/14/2025	Northern Trust Corp	465,261	$3.60M	0.0%	-4.7%	0.939%
2/14/2025	Voya Investment Management LLC	43,502	$0.34M	0.0%	+7.5%	0.088%
2/14/2025	Adage Capital Partners GP L.L.C.	500,000	$3.87M	0.0%	N/A	1.009%
2/14/2025	Price T Rowe Associates Inc. MD	23,910	$0.19M	0.0%	+9.0%	0.048%
2/14/2025	Quantessence Capital LLC	34,888	$0.27M	0.1%	N/A	0.070%
2/14/2025	Alpine Global Management LLC	22,687	$0.18M	0.0%	N/A	0.046%
2/14/2025	Hsbc Holdings PLC	84,817	$0.63M	0.0%	+132.3%	0.171%
2/14/2025	Stifel Financial Corp	188,844	$1.46M	0.0%	+26.5%	0.381%
2/14/2025	State of Tennessee Department of Treasury	10,869	$84K	0.0%	-43.8%	0.022%
2/14/2025	Voss Capital LP	332,814	$2.57M	0.2%	N/A	0.672%
2/14/2025	Tower Research Capital LLC TRC	13,138	$0.10M	0.0%	+442.0%	0.027%
2/14/2025	Dimensional Fund Advisors LP	1,171,422	$9.05M	0.0%	+1.8%	2.365%
2/13/2025	CANADA LIFE ASSURANCE Co	6,649	$51K	0.0%	-84.7%	0.013%
2/13/2025	Jump Financial LLC	192,708	$1.49M	0.0%	+144.9%	0.389%
2/13/2025	Walleye Capital LLC	88,148	$0.68M	0.0%	N/A	0.178%
2/13/2025	XTX Topco Ltd	108,120	$0.84M	0.1%	+720.5%	0.218%
2/13/2025	Barclays PLC	127,065	$0.98M	0.0%	+9.5%	0.256%
2/13/2025	Rockefeller Capital Management L.P.	27,108	$0.21M	0.0%	-33.8%	0.055%
2/13/2025	Raymond James Financial Inc.	73,510	$0.57M	0.0%	N/A	0.148%
2/13/2025	Renaissance Technologies LLC	271,300	$2.10M	0.0%	N/A	0.548%
2/13/2025	Legal & General Group Plc	44,823	$0.35M	0.0%	-63.1%	0.090%
2/13/2025	Invesco Ltd.	52,128	$0.40M	0.0%	-61.7%	0.105%
2/13/2025	ArchPoint Investors	221,528	$1.71M	0.6%	-1.2%	0.447%
2/13/2025	Aristides Capital LLC	24,200	$0.19M	0.0%	N/A	0.049%
2/13/2025	Dynamic Technology Lab Private Ltd	10,159	$79K	0.0%	N/A	0.021%
2/13/2025	Wells Fargo & Company MN	48,437	$0.37M	0.0%	+34.0%	0.098%
2/12/2025	ExodusPoint Capital Management LP	105,668	$0.82M	0.0%	-44.1%	0.213%
2/12/2025	Trexquant Investment LP	150,022	$1.16M	0.0%	N/A	0.303%
2/12/2025	Geode Capital Management LLC	1,094,225	$8.46M	0.0%	+0.5%	2.209%
2/12/2025	Alliancebernstein L.P.	53,900	$0.42M	0.0%	-8.7%	0.109%
2/12/2025	DnB Asset Management AS	14,539	$0.11M	0.0%	+20.1%	0.029%
2/12/2025	Norges Bank	449,400	$3.47M	0.0%	N/A	0.907%
2/12/2025	BIT Capital GmbH	29,696	$0.23M	0.0%	N/A	0.060%
2/12/2025	JPMorgan Chase & Co.	4,136,517	$31.98M	0.0%	+67.0%	8.350%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	25,430	$0.20M	0.0%	+48.2%	0.051%
2/11/2025	EntryPoint Capital LLC	12,538	$97K	0.0%	N/A	0.025%
2/11/2025	Corebridge Financial Inc.	22,889	$0.18M	0.0%	-13.3%	0.046%
2/11/2025	Vanguard Group Inc.	2,985,952	$23.08M	0.0%	-31.7%	6.027%
2/11/2025	Napatree Capital LLC	33,525	$0.26M	0.2%	-4.6%	0.068%
2/11/2025	KLP Kapitalforvaltning AS	7,000	$54K	0.0%	N/A	0.014%
2/11/2025	AXQ Capital LP	13,732	$0.11M	0.0%	N/A	0.028%
2/11/2025	American Century Companies Inc.	95,026	$0.74M	0.0%	+8.8%	0.192%
2/11/2025	Teacher Retirement System of Texas	12,590	$97K	0.0%	+19.9%	0.025%
2/7/2025	AlphaQuest LLC	7,959	$62K	0.0%	-66.9%	0.016%
2/6/2025	Raymond James Financial Inc.	73,510	$0.57M	0.0%	N/A	0.148%
2/6/2025	Charles Schwab Investment Management Inc.	349,730	$2.70M	0.0%	-16.3%	0.706%
2/4/2025	Bank of New York Mellon Corp	161,136	$1.25M	0.0%	-49.7%	0.325%
2/4/2025	Y Intercept Hong Kong Ltd	137,402	$1.06M	0.1%	N/A	0.277%
1/31/2025	New York State Common Retirement Fund	13,746	$0.11M	0.0%	-17.4%	0.028%
1/30/2025	Rhumbline Advisers	74,269	$0.57M	0.0%	-35.4%	0.150%
1/17/2025	SG Americas Securities LLC	10,375	$80K	0.0%	-25.6%	0.021%
1/15/2025	Hennion & Walsh Asset Management Inc.	164,729	$1.27M	0.1%	+8.6%	0.332%
1/14/2025	Assenagon Asset Management S.A.	856,572	$6.62M	0.0%	+53.0%	1.729%
1/10/2025	Harbor Capital Advisors Inc.	25,607	$0.20M	0.0%	-29.0%	0.052%
1/3/2025	GAMMA Investing LLC	3,429	$27K	0.0%	+273.1%	0.007%
12/26/2024	JPMorgan Chase & Co.	2,477,311	$25.99M	0.0%	-17.8%	5.000%
12/19/2024	Principal Financial Group Inc.	214,353	$2.25M	0.0%	-4.9%	0.433%
11/19/2024	Barclays PLC	116,024	$1.22M	0.0%	+141.3%	0.234%
11/16/2024	Geode Capital Management LLC	1,088,651	$11.42M	0.0%	+4.2%	2.198%
11/15/2024	Barclays PLC	116,024	$1.22M	0.0%	+141.3%	0.234%
11/15/2024	XTX Topco Ltd	13,177	$0.14M	0.0%	-75.0%	0.027%
11/15/2024	National Bank of Canada FI	68,000	$0.71M	0.0%	N/A	0.137%
11/15/2024	Jane Street Group LLC	38,776	$0.41M	0.0%	-48.1%	0.078%
11/15/2024	State Street Corp	2,782,883	$29.19M	0.0%	-3.1%	5.617%
11/15/2024	Stifel Financial Corp	149,280	$1.57M	0.0%	+13.3%	0.301%
11/15/2024	Redmile Group LLC	4,892,902	$51.33M	3.0%	+7.1%	9.877%
11/15/2024	Jacobs Levy Equity Management Inc.	89,218	$0.94M	0.0%	-41.5%	0.180%
11/15/2024	Erste Asset Management GmbH	13,000	$0.14M	0.0%	N/A	0.026%
11/14/2024	Verition Fund Management LLC	41,146	$0.43M	0.0%	N/A	0.083%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	66,078	$0.69M	0.0%	-6.9%	0.133%
11/14/2024	Public Sector Pension Investment Board	96,476	$1.01M	0.0%	-3.2%	0.195%
11/13/2024	BNP Paribas Financial Markets	20,441	$0.21M	0.0%	+602.9%	0.041%
11/13/2024	FMR LLC	2,649	$28K	0.0%	+166.8%	0.005%

Data available starting January 2016

See Full Table

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

Today's Range

Now: $7.83

$7.68

$7.96

50 Day Range

MA: $7.40

$5.92

$8.70

52 Week Range

Now: $7.83

$5.62

$21.57

Volume

404,170 shs

Average Volume

765,948 shs

Market Capitalization

$392.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Who are the company insiders with the largest holdings of REGENXBIO?: REGENXBIO's top insider shareholders include:
Kenneth T Mills (CEO)
Kenneth T Mills (Director)
Curran Simpson (CEO)
Steve Pakola (Insider)
Argeris N Karabelas (Director)
Learn More about top insider investors at REGENXBIO.
Who are the major institutional investors of REGENXBIO?: REGENXBIO's top institutional investors include:
Redmile Group LLC — 9.68%
JPMorgan Chase & Co. — 8.35%
Vanguard Group Inc. — 6.03%
Millennium Management LLC — 2.67%
Balyasny Asset Management L.P. — 2.40%
Dimensional Fund Advisors LP — 2.36%
Learn More about top institutional investors of REGENXBIO stock.
Which institutional investors are selling REGENXBIO stock?: In the previous quarter, RGNX stock was sold by these institutional investors:
Vanguard Group Inc.
Jefferies Financial Group Inc.
Jefferies Financial Group Inc.
Integral Health Asset Management LLC
Bank of America Corp DE
Bank of New York Mellon Corp
Redmile Group LLC
Invesco Ltd.
In the previous year, company insiders that have sold REGENXBIO company stock include:
Kenneth T Mills (CEO)
Kenneth T Mills (Director)
Curran Simpson (CEO)
Steve Pakola (Insider)
Learn More investors selling REGENXBIO stock.
Which institutional investors are buying REGENXBIO stock?: Within the previous quarter, RGNX stock was bought by institutional investors including:
JPMorgan Chase & Co.
Millennium Management LLC
Adage Capital Partners GP L.L.C.
Norges Bank
Cubist Systematic Strategies LLC
Voss Capital LP
Assenagon Asset Management S.A.
Renaissance Technologies LLC